We are pleased that Spice Route Legal's Life Sciences and Healthcare practice has been ranked as a Tier 1 practice by one of the world's foremost directories for law firms and lawyers, Legal500, in its 2023 guide for the Indian region!
The firm has been recognised for offering "full service to pharma, primary healthcare, medical devices, and biotech companies, encompassing cross-border transactional support for both M&A and private equity investments, regulatory compliance advice, commercial and distribution agreements, and utilising the firm's intellectual property practice in support with patent filings."
Our cross-border expertise also been acknowledged by Legal500 – "The team acts for a wide range of international clients, including major domestic drug producers and healthcare providers, international pharma giants, and investment funds, further benefitting from connections to a strong network of international law firms."
Legal500 in its observations on the market in general specifically commended our practice, "The life sciences and healthcare space has continued to flourish, with India's status as a major global vaccine producer only consolidated by the Covid-19 pandemic. Alongside vaccine production, other drivers of activity for firms include drug development, production, and approval. Firms active in the Indian life sciences and healthcare sectors tend to combine transactional, regulatory, and IP expertise so as to provide a full service to clients, with standouts including Spice Route Legal..."
Our clients have testified to our skills, stating that the "SRL team is unique in the sense that the advice provided by them makes a lot of commercial sense, blended with a solid legal structuring".
Our practice head, Praveen Raju, has found mention for having "significant expertise in the life sciences space, including advising on cross-border transactions, joint ventures, and commercial agreements." Legal500 has recognised his mettle, and particularly acknowledged his promptness, his "cooperative and engaging" demeanour, as well as his "excellent legal oversight".
Several of our other leading lawyers have also received recognition. Mathew Chacko has been acknowledged as a key figure, "leading on M&A and private equity transactions with significant data, IP, and technology elements". Senior Associate Renuka Abraham has also been recognised for her "strong focus on M&A within the sector".